spacer
home > pmps > summer 2002 > new manufacturing technologies - from drug discovery to final product
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

New Manufacturing Technologies - From Drug Discovery to Final Product

Anyone working within the life sciences industries knows that it takes significant investments of time, human and monetary resources to bring a new drug from discovery to the finished goods state. During the last decade, average times for this process peaked at 15 years from inception to launch. During that time, all pharmaceutical firms worked aggressively to reduce the time to develop and market, and the late 1990s saw dramatic reductions (some as much as 40 per cent, but on average, reductions took the process from 15 years to around nine to 10 years).

The industry was once quite unique in its record of business success. With high growth rates, barriers to entry and profits, the pharmaceutical industry was recognised as one of the most successful business spaces in the world marketplace. Recent years, however, have seen the industry running up against a number of unforeseen changes in the manufacturing life cycle.

These changes have inhibited the development, marketing and eventual sales of new drugs, and have increased potential risks and the costs associated with them. Similar changes have taken place across the breadth of life sciences manufacturing, extending beyond pharmaceuticals to nutraceuticals/ dietary supplements, to clinical and biotech manufacturing, resulting in heightened risk, threats to agility, challenges in enterprise-wide collaboration, and impaired time to market.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Benjamin Bryant, Global Communications, at Honeywell Industry Solutions for Chemicals, Life Sciences and Consumer Goods Benjamin Bryant co-ordinates global communications for Honeywell's Chemicals, Life Sciences, and Consumer Goods business, his employer since 2000, when he represented the POMS business exclusively. Prior appointments include service as well-known radio and news presenter in Austin, Texas, and work for the United States Army & Exchange Service in merchandising and promotions.
Benjamin is a member of the Association of the United States Army and the Public Relations Society of America, where he serves on the 12-member executive board of the society's international section. He has attended the University of Texas and the business programme at the University of Phoenix.

spacer
Benjamin Bryant
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Merck Introduces Parteck® COAT Excipient, a Fast-Dissolving Material for Immediate Release Coating

• Designed to simplify the formulation and coating process for tablets • Optimized particle size leads to fast dissolving and increases coating process efficiency Merck has launched its Parteck® COAT excipient, a new functional material designed for immediate release film coating applications. Parteck® COAT is a particle engineered polyvinyl alcohol (PVA) with a unique particle structure that enables rapid dissolution even at low temperatures leading to an increased process efficiency.
More info >>

White Papers

BioT ULT Transporter

BioCision

The growth of biobanking, cell therapy, and complex biopharmaceutical therapies like cancer vaccines has created a strong need for products and processes to ensure the stability of temperature­-sensitive biospecimens. Proper collection, handling, characterization, packaging and shipping of these materials is critical, as poor sample handling impacts researchers working on discovery with patient samples, as well as clinicians treating patients with cutting edge therapies. This white paper describes in detail the BioCision BioT™ ULT Transporter, the first-of-its-kind dry ice-based portable cooling system that maintains a stable -75° to -50°C environment for over 24 hours on one charge of dry ice, enabling reliable handling and transfer of valuable temperature-sensitive biospecimens as part of a larger cold chain standardization process.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement